Лучшие больницы для «Uterine Prolapse Surgery» в Хайдарабад, Индия

Uterine prolapse occurs when the structural integrity of the pelvic floor — comprising the levator ani muscle complex, endopelvic fascia, and uterosacral-cardinal ligament system — is compromised to the degree that the uterus descends into or beyond the vaginal canal. Graded using the validated Pelvic Organ Prolapse Quantification (POP-Q) system from Stage I (above the hymen) to Stage IV (complete procidentia), symptomatic prolapse typically becomes surgically relevant at Stage II or above. Pathophysiological contributors include obstetric trauma (particularly multiparity and prolonged second-stage labour), collagen deficiency disorders, oestrogen depletion post-menopause, chronic elevated intra-abdominal pressure (obesity, chronic cough, constipation), and prior pelvic surgery. The physiological consequences extend beyond the uterus itself, frequently involving concomitant cystocele (anterior wall prolapse causing urinary retention or stress urinary incontinence) and rectocele (posterior wall prolapse causing obstructed defaecation), necessitating a comprehensive multi-compartment surgical approach.

• ELIGIBLE PATIENTS:
• Women with symptomatic uterine prolapse classified as POP-Q Stage II–IV who have failed or declined conservative management (structured pelvic floor physiotherapy for ≥3–6 months; optimised pessary therapy)
• Patients with bothersome bulge symptoms, urinary dysfunction (retention, urgency, stress incontinence), obstructed defaecation, sexual dysfunction, or pelvic pain attributable to prolapse
• Women with concurrent anterior compartment defect (cystocele) or posterior compartment defect (rectocele) requiring combined multi-compartment repair
• Post-menopausal women with Stage III–IV prolapse (most common surgical group)
• +22 more

CONSERVATIVE (NON-SURGICAL) APPROACHES — Baseline Before Surgery:

• Pelvic floor muscle training (PFMT): supervised physiotherapy with biofeedback, targeting levator ani strength; effective for Stage I–II and as surgical preamble to improve tissue quality
• Vaginal pessary therapy: silicone ring, Gellhorn, or cube pessary fitted by specialist; achieves symptom control in ~60% of women, particularly elderly or surgically unfit patients; requires 3–6 monthly review
• Topical oestrogen therapy: low-dose vaginal oestradiol (cream or pessary) in post-menopausal women to improve vaginal epithelial quality and tissue tensile strength prior to surgery

SURGICAL PROCEDURES — Native Tissue Repairs (Vaginal Route):

• Vaginal Hysterectomy with Vault Suspension: Removal of the uterus through the vaginal route followed by apical support reconstruction. Concomitant vault suspension techniques include:
• McCall Culdoplasty: Intraoperative plication of uterosacral ligaments to the vaginal cuff; reduces vault prolapse recurrence
• Uterosacral Ligament Suspension (USLS): Bilateral suture fixation of the vaginal cuff to the high uterosacral ligaments at the level of the ischial spine; OPTIMAL trial evidence supports equivalent long-term outcomes to sacrospinous fixation
• Sacrospinous Ligament Fixation (SSLF / Richter Procedure): Unilateral or bilateral fixation of the vaginal cuff to the sacrospinous ligament using permanent or delayed-absorbable sutures (or suture-capture devices such as Capio); well-evidenced for long-term apical support
• Anterior Colporrhaphy: Midline plication of pubocervical fascia for cystocele correction; performed concomitantly with apical repair
• Posterior Colporrhaphy with Perineorrhaphy: Site-specific or midline fascial repair for rectocele and perineal descent
• Colpocleisis (Le Fort Procedure): Obliterative procedure for elderly, sexually inactive women with severe prolapse and high surgical risk; partial colpocleisis for post-hysterectomy vault prolapse; highly effective (success rate >95%) with low morbidity

PHASE 1 — REMOTE PRE-CONSULTATION (Weeks 1–4 Before Travel):

• Step 1: GAF Healthcare coordinator receives patient inquiry; shares a standardised Gynaecology Intake Questionnaire covering POP-Q staging reports, urodynamics results, MRI/ultrasound findings, obstetric and surgical history, and current medications
• Step 2: Medical records reviewed by GAF's in-house clinical advisory team; shortlisted urogynecologist profiles and hospital options shared with patient within 48 hours
• Step 3: Teleconsultation with chosen surgeon (Zoom/Teams); surgeon reviews imaging, discusses procedure selection (e.g., robotic sacrocolpopexy vs. vaginal hysterectomy + USLS), confirms candidacy, and provides a written Treatment Plan with itemised cost estimate
• Step 4: GAF Healthcare assists with e-Medical Visa application for India (typically approved in 3–5 business days) or visit/medical visa for UAE; flight and accommodation recommendations provided

PHASE 2 — PRE-OPERATIVE IN-COUNTRY (Days 1–3 After Arrival):